Defining the regulation of IL-1β- and CHOP-mediated β-cell apoptosis

Nathan L Vanderford1

  • 1Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA. nathan.vanderford@uky.edu

Islets
|November 25, 2010
PubMed

Insights

Understanding the molecular mechanisms of diabetes is crucial for developing new treatments. This commentary highlights the complexity of pancreatic beta-cell dysfunction and proposes advanced in vitro models for better insights into diabetes progression.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Metabolic Disorders

Background:

  • Diabetes mellitus is a complex metabolic disorder involving pancreatic beta-cell destruction (Type 1) or failure (Type 2).
  • While clinical aspects are understood, the molecular events driving beta-cell dysfunction in diabetes remain unclear.
  • Interactions between physiological signals contributing to disease development are particularly poorly understood.

Purpose of the Study:

  • To summarize a report on Interleukin-1 beta (IL-1β)-induced beta-cell apoptosis.
  • To discuss the complexity of beta-cell regulation in the context of diabetes.
  • To advocate for advanced in vitro systems for studying diabetes molecular mechanisms.

Main Methods:

  • Commentary and synthesis of existing research.
  • Focus on a specific report detailing IL-1β's role in beta-cell apoptosis.
  • Discussion of complex in vitro models mimicking in vivo conditions.

Main Results:

  • IL-1β can induce beta-cell apoptosis, highlighting a complex molecular pathway in diabetes.
  • Beta-cell regulation involves intricate signaling networks.
  • Current in vitro models may not fully capture in vivo complexity.

Conclusions:

  • Understanding the molecular etiology of beta-cell dysfunction is key to novel diabetes therapies.
  • Advanced in vitro models are needed to better elucidate diabetes pathogenesis.
  • Further research into molecular mechanisms can enhance therapeutic interventions for diabetes.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...